Literature DB >> 15847991

Surfactant solubility and aggregate orientation in hydrofluoroalkanes.

Kristin B Ridder1, Craig J Davies-Cutting, Ian W Kellaway.   

Abstract

PURPOSE: To find surfactants soluble in the two hydrofluoroalkane (HFA) propellants, HFA-134a and HFA-227ea; to compare surfactant solubility in the two propellants with those in 2H,3H-decafluoropentane (DFP) in order to assess latter's suitability as a liquid model propellant and to investigate surfactant aggregation and aggregate orientation in HFAs.
METHODS: To assess surfactant solubility, HFA was added to a known amount of surfactant until dissolution was visibly apparent. An iodine solubilization method was used to determine surfactant aggregation behaviour in DFP. Fluorescence spectroscopic investigations on the surfactant orientation in aggregates were carried out in HFAs using a microviscosity sensitive fluorescent probe (1,3-dipyrenylpropane). The aim was to assess viscosity changes in the microenvironment of this lipophilic probe upon incorporation into surfactant aggregates.
RESULTS: Soluble surfactants could be found among the polyoxyethylene-ethers and POE-PPO-block copolymer surfactants. Solubility in DFP appears to correlate with solubility in HFA-134a, but not HFA-227ea. Iodine solubilization indicates micellization of Brij 30 in DFP at a cmc (type II association behaviour). L-44 in DFP, on the other hand, does not exhibit a well defined cmc, but shows continuous surfactant aggregation (type I association behaviour). The fluorescence spectroscopic studies showed evidence for probe incorporation into surfactant aggregates in HFAs.
CONCLUSIONS: DFP proved to be a good model for HFA-134a only. An L1-aggregate orientation was shown for surfactants in HFAs and is in marked contrast to the chlorofluorocarbon propellant where a L2-aggregate orientation exists.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15847991     DOI: 10.1016/j.ijpharm.2005.01.027

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

Review 1.  Advances in metered dose inhaler technology: formulation development.

Authors:  Paul B Myrdal; Poonam Sheth; Stephen W Stein
Journal:  AAPS PharmSciTech       Date:  2014-01-23       Impact factor: 3.246

2.  Pulmonary-Affinity Paclitaxel Polymer Micelles in Response to Biological Functions of Ambroxol Enhance Therapeutic Effect on Lung Cancer.

Authors:  Wenxiu He; Wenze Xiao; Xiulei Zhang; Yali Sun; Yiting Chen; Qinyue Chen; Xiaoling Fang; Shilin Du; Xianyi Sha
Journal:  Int J Nanomedicine       Date:  2020-02-04

3.  Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants.

Authors:  Imran Y Saleem; Hugh D C Smyth
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.